Insurance and genetic testing: where are we now?

Area of Science:

• Genetics and Public Health
• Bioethics
• Insurance Law

Background:

• Advancements in basic research are enabling genetic tests for presymptomatic disease prediction.
• Concerns exist regarding the misuse of genetic information, including privacy breaches, eugenics, and discrimination.
• Current legal and administrative frameworks may inadequately protect genetic information.

Purpose of the Study:

• To review insurance systems (life, health, disability) and their principles.
• To examine risk classification, market dynamics, and regulatory aspects within the insurance industry.
• To assess the potential impact of genetic information on the insurance sector.

Main Methods:

• Review of existing literature on insurance principles and regulation.
• Analysis of potential implications of genetic testing on insurance underwriting.
• Examination of ethical, legal, and social issues related to genetic information.

Main Results:

• Genetic testing poses challenges to traditional insurance risk classification.
• Potential for genetic discrimination in insurance markets necessitates policy review.
• Existing regulations may not sufficiently address the complexities of genetic information.

Conclusions:

• Sound social policy is needed to guide the fair use of genetic information in insurance.
• The insurance industry must adapt to the implications of genetic testing.
• Further study is required to develop robust legal and ethical safeguards.